X-Therma key facts
- Provider of biopreservation technology intended for long-term storage of biological materials.
- It has raised $36.7M across 3 recorded rounds; the latest was Early Stage VC ($22.4M) in Mar 2024.
- Notable investors include US National Science Foundation, United States Department of War, VU Venture Partners, LIFTT, Catalytic Impact Foundation — 15 tracked in total.
- X-Therma has filed 3 Form Ds with the SEC since 2021, most recently Mar 2024 ($22.4M sold to 39 investors).
- Status: Privately Held (backing).
Who backs X-Therma
15+- ·The complete investor list: 15 names
- ·Watch X-Therma: the Monday email on marks, rounds and moves
X-Therma funding rounds
3 roundsHow much has X-Therma raised?
X-Therma has raised $36.7 million across 3 recorded rounds since 2021. The largest was a $2.6 million seed round in Dec 2021; the most recent was a $22.4 million early-stage round in Mar 2024.
X-Therma has filed 3 Form Ds with the SEC since 2021, most recently in Mar 2024 ($22.4 million sold to 39 investors).
X-Therma investors
15 investors are on record for X-Therma, including US National Science Foundation, United States Department of War, VU Venture Partners and LIFTT. The early-stage round in Mar 2024 drew 39 investors.
About X-Therma
Provider of biopreservation technology intended for long-term storage of biological materials. The company leverages proprietary peptoid technology to inhibit ice crystal formation, allowing sub-zero storage of cells, tissues, and organs while maintaining their functionality and viability, enabling healthcare and research institutions to preserve samples effectively, supporting advancements in regenerative medicine and transplantation.
- Sector
- Healthcare
- HQ
- Hercules, CA, United States
- Founded
- 2014
- Employees
- 33
- Website
- x-therma.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
X-Therma doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.